Completed
Efficacy and Safety of Subcutaneous Secukinumab in Adults With Moderate to Severe Scalp Psoriasis
NCT02267135
- Conditions
- Chronic Scalp Psoriasis, Psoriasis, Skin Diseases, +2 more
- Locations
-
- Novartis Investigative Site Sacramento, California, United States
- Novartis Investigative Site Aurora, Colorado, United States
- Novartis Investigative Site Trumbull, Connecticut, United States
- Novartis Investigative Site Rockville, Maryland, United States